204 related articles for article (PubMed ID: 27519966)
1. Porta hepatis peritonectomy and hepato-celiac lymphadenectomy in patients with stage IIIC-IV ovarian cancer: Diagnostic pathway, surgical technique and outcomes.
Tozzi R; Traill Z; Garruto Campanile R; Ferrari F; Soleymani Majd H; Nieuwstad J; Hardern K; Gubbala K
Gynecol Oncol; 2016 Oct; 143(1):35-39. PubMed ID: 27519966
[TBL] [Abstract][Full Text] [Related]
2. Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.
Tozzi R; Giannice R; Cianci S; Tardino S; Campanile RG; Gubbala K; Fachechi G; Ferrari F; Martinek I; Soleymani Majd H
Gynecol Oncol; 2015 Aug; 138(2):252-8. PubMed ID: 26003142
[TBL] [Abstract][Full Text] [Related]
3. Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Martinez A; Pomel C; Mery E; Querleu D; Gladieff L; Ferron G
Gynecol Oncol; 2011 May; 121(2):258-63. PubMed ID: 21295334
[TBL] [Abstract][Full Text] [Related]
4. The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer.
Turnbull HL; Akrivos N; Wemyss-Holden S; Maiya B; Duncan TJ; Nieto JJ; Burbos N
Arch Gynecol Obstet; 2017 Mar; 295(3):681-687. PubMed ID: 27995370
[TBL] [Abstract][Full Text] [Related]
5. Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during Visceral-Peritoneal Debulking (VPD) in 100 consecutive patients with stage IIIC-IV ovarian cancer: A surgical-histological analysis.
Soleymani Majd H; Ferrari F; Manek S; Gubbala K; Campanile RG; Hardern K; Tozzi R
Gynecol Oncol; 2016 Mar; 140(3):430-5. PubMed ID: 26691220
[TBL] [Abstract][Full Text] [Related]
6. Peritonectomy and resection of mesentery during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer: A phase I-II trial.
Tozzi R; Noventa M; Spagnol G; De Tommasi O; Coldebella D; Tamagnini M; Bigardi S; Saccardi C; Marchetti M
Eur J Surg Oncol; 2024 Feb; 50(2):107957. PubMed ID: 38219700
[TBL] [Abstract][Full Text] [Related]
7. Correlation of pre-operative CT findings with surgical & histological tumor dissemination patterns at cytoreduction for primary advanced and relapsed epithelial ovarian cancer: A retrospective evaluation.
Nasser S; Lazaridis A; Evangelou M; Jones B; Nixon K; Kyrgiou M; Gabra H; Rockall A; Fotopoulou C
Gynecol Oncol; 2016 Nov; 143(2):264-269. PubMed ID: 27586894
[TBL] [Abstract][Full Text] [Related]
8. A prospective study on the diagnostic pathway of patients with stage IIIC-IV ovarian cancer: Exploratory laparoscopy (EXL) + CT scan VS. CT scan.
Tozzi R; Traill Z; Valenti G; Ferrari F; Gubbala K; Campanile RG
Gynecol Oncol; 2021 Apr; 161(1):188-193. PubMed ID: 33514484
[TBL] [Abstract][Full Text] [Related]
9. En-bloc resection of the pelvis (EnBRP) in patients with stage IIIC-IV ovarian cancer: A 10 steps standardised technique. Surgical and survival outcomes of primary vs. interval surgery.
Tozzi R; Hardern K; Gubbala K; Garruto Campanile R; Soleymani Majd H
Gynecol Oncol; 2017 Mar; 144(3):564-570. PubMed ID: 28073597
[TBL] [Abstract][Full Text] [Related]
10. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.
Suidan RS; Ramirez PT; Sarasohn DM; Teitcher JB; Iyer RB; Zhou Q; Iasonos A; Denesopolis J; Zivanovic O; Long Roche KC; Sonoda Y; Coleman RL; Abu-Rustum NR; Hricak H; Chi DS
Gynecol Oncol; 2017 Apr; 145(1):27-31. PubMed ID: 28209497
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.
Angeles MA; Ferron G; Cabarrou B; Balague G; Martínez-Gómez C; Gladieff L; Pomel C; Martinez A
Eur J Surg Oncol; 2019 Aug; 45(8):1410-1416. PubMed ID: 30857876
[TBL] [Abstract][Full Text] [Related]
12. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y
Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of laparoscopic diaphragmatic peritonectomy during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.
Tozzi R; Soleymani Majd H; Campanile RG; Ferrari F
J Gynecol Oncol; 2020 Sep; 31(5):e71. PubMed ID: 32808498
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
Song N; Gao Y
Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
[TBL] [Abstract][Full Text] [Related]
15. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
[TBL] [Abstract][Full Text] [Related]
16. Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre- and postoperative imaging.
Salehi S; Mohammar R; Suzuki C; Joneborg U; Hjerpe E; Torbrand C; Falconer H
Acta Oncol; 2018 Jun; 57(6):820-824. PubMed ID: 29182048
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer.
Paik ES; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS
J Gynecol Oncol; 2016 May; 27(3):e24. PubMed ID: 27029745
[TBL] [Abstract][Full Text] [Related]
18. En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer.
Yildirim Y; Ertas IE; Nayki U; Ulug P; Nayki C; Yilmaz I; Gultekin E; Dogan A; Aykas A; Ulug S; Ozdemir A; Solmaz U
Eur J Gynaecol Oncol; 2014; 35(4):400-7. PubMed ID: 25118481
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer.
Prader S; Harter P; Grimm C; Traut A; Waltering KU; Alesina PF; Heikaus S; Ataseven B; Heitz F; Schneider S; du Bois A
Gynecol Oncol; 2016 May; 141(2):271-275. PubMed ID: 26972337
[TBL] [Abstract][Full Text] [Related]
20. What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.
Rungruang BJ; Miller A; Krivak TC; Horowitz NS; Rodriguez N; Hamilton CA; Backes FJ; Carson LF; Friedlander M; Mutch DG; Goodheart MJ; Tewari KS; Wenham RM; Bookman MA; Maxwell GL; Richard SD
Cancer; 2017 May; 123(6):985-993. PubMed ID: 27864921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
